carcinoma
-
AstraZeneca receives CDSCO approval for Tremelimumab combination in India
Tremelimumab in combination with Durvalumab is indicated for the treatment of patients with unresectable hepatocellular carcinoma (uHCC) AstraZeneca Pharma India…
Read More » -
Male breast cancer patients at increased risk of heart disease risk factors: Study
Due to the rarity of male breast cancer, there is no cardiovascular data from larger clinical trials or population studies…
Read More »